Clover Health Investments Stock EBITDA
| CLOV Stock | USD 1.01 0.01 1.00% |
Clover Health Investments fundamentals help investors to digest information that contributes to Clover Health's financial success or failures. It also enables traders to predict the movement of Clover Stock. The fundamental analysis module provides a way to measure Clover Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clover Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -180.2 M | -189.2 M |
Clover | EBITDA |
Clover Health Investments Company EBITDA Analysis
Clover Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Clover Health EBITDA | (180.16 M) |
Most of Clover Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clover Health Investments is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Clover EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Clover Health is extremely important. It helps to project a fair market value of Clover Stock properly, considering its historical fundamentals such as EBITDA. Since Clover Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Clover Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Clover Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Clover Ebitda
According to the company disclosure, Clover Health Investments reported earnings before interest,tax, depreciation and amortization of (180.16 Million). This is 120.53% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 104.62% higher than that of the company.
Clover EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clover Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clover Health could also be used in its relative valuation, which is a method of valuing Clover Health by comparing valuation metrics of similar companies.Clover Health is currently under evaluation in ebitda category among related companies.
Clover Health Institutional Holders
Institutional Holdings refers to the ownership stake in Clover Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Clover Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Clover Health's value.| Shares | Two Sigma Investments Llc | 2024-03-31 | 2.5 M | Gmt Capital Corp | 2024-03-31 | 1.3 M | Jane Street Group, Llc | 2023-12-31 | 1.3 M | Goldman Sachs Group Inc | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 878.3 K | Amvescap Plc. | 2023-12-31 | 854.5 K | Connor Clark & Lunn Inv Mgmt Ltd | 2023-12-31 | 829.9 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 814.6 K | Millennium Management Llc | 2024-03-31 | 813.8 K | Vanguard Group Inc | 2024-03-31 | 17.7 M | Renaissance Technologies Corp | 2023-12-31 | 12.6 M |
Clover Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 128.49 M | ||||
| Shares Outstanding | 406.79 M | ||||
| Shares Owned By Insiders | 9.30 % | ||||
| Shares Owned By Institutions | 22.65 % | ||||
| Number Of Shares Shorted | 45.33 M | ||||
| Price To Book | 1.16 X | ||||
| Price To Sales | 0.16 X | ||||
| Revenue | 2.03 B | ||||
| Gross Profit | 126.19 M | ||||
| EBITDA | (180.16 M) | ||||
| Net Income | (213.36 M) | ||||
| Cash And Equivalents | 711.78 M | ||||
| Cash Per Share | 1.49 X | ||||
| Total Debt | 4.66 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 0.59 X | ||||
| Cash Flow From Operations | (115.87 M) | ||||
| Short Ratio | 6.45 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Price To Earnings To Growth | (0.08) X | ||||
| Target Price | 1.44 | ||||
| Number Of Employees | 552 | ||||
| Beta | 1.85 | ||||
| Market Capitalization | 496.44 M | ||||
| Total Asset | 570.67 M | ||||
| Retained Earnings | (2.16 B) | ||||
| Working Capital | 166.85 M | ||||
| Net Asset | 570.67 M |
About Clover Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clover Health Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clover Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clover Health Investments based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Clover Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clover Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clover Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Clover Stock
| 0.74 | GH | Guardant Health Earnings Call Tomorrow | PairCorr |
| 0.68 | FIGS | Figs Inc Earnings Call Next Week | PairCorr |
Moving against Clover Stock
| 0.52 | IRIX | IRIDEX | PairCorr |
| 0.45 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to Clover Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clover Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clover Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clover Health Investments to buy it.
The correlation of Clover Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clover Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clover Health Investments moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clover Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Clover Health Piotroski F Score and Clover Health Altman Z Score analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Clover Stock analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Clover Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clover Health. If investors know Clover will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clover Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 4.211 | Quarterly Revenue Growth (0.34) | Return On Assets (0.17) | Return On Equity (0.66) |
The market value of Clover Health Investments is measured differently than its book value, which is the value of Clover that is recorded on the company's balance sheet. Investors also form their own opinion of Clover Health's value that differs from its market value or its book value, called intrinsic value, which is Clover Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clover Health's market value can be influenced by many factors that don't directly affect Clover Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clover Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clover Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clover Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.